These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 25252195
1. Vaccine safety implications of Ontario, Canada's switch from DTaP-IPV to Tdap-IPV for the pre-school booster. Klar S, Harris T, Wong K, Fediurek J, Deeks SL. Vaccine; 2014 Nov 12; 32(48):6360-3. PubMed ID: 25252195 [Abstract] [Full Text] [Related]
2. Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children. Kemmeren JM, Timmer SS, van der Maas NA, de Melker HE. Vaccine; 2011 Jun 10; 29(26):4373-7. PubMed ID: 21514347 [Abstract] [Full Text] [Related]
9. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR, Pentacel Study Group. Pediatrics; 2009 Jan 10; 123(1):301-12. PubMed ID: 19117896 [Abstract] [Full Text] [Related]
10. Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6years. Southern J, Waight PA, Andrews N, Miller E. Vaccine; 2017 Jan 23; 35(4):619-625. PubMed ID: 28017441 [Abstract] [Full Text] [Related]
11. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). Johns TL, Hutter GE. Ann Pharmacother; 2010 Mar 23; 44(3):515-23. PubMed ID: 20197476 [Abstract] [Full Text] [Related]
12. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children. Klein NP, Weston WM, Kuriyakose S, Kolhe D, Howe B, Friedland LR, Van Der Meeren O. Vaccine; 2012 Jan 11; 30(3):668-74. PubMed ID: 22064267 [Abstract] [Full Text] [Related]
13. Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years. Black S, Friedland LR, Schuind A, Howe B, GlaxoSmithKline DTaP-IPV Vaccine Study Group. Vaccine; 2006 Aug 28; 24(35-36):6163-71. PubMed ID: 16759769 [Abstract] [Full Text] [Related]
15. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Oct 03; 57(39):1078-9. PubMed ID: 18830212 [Abstract] [Full Text] [Related]
20. Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children. Lee SM, Kim SJ, Chen J, Song R, Kim JH, Devadiga R, Kim YK. Hum Vaccin Immunother; 2019 Oct 03; 15(5):1145-1153. PubMed ID: 30668217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]